Category: Press Release

Posted on

Personal Care ingredient Market is expected to grow to $18.5 billion by 2031 at a CAGR of 6% from 2022 to 2031

Personal Care ingredient Market

According to the research report published by Allied Market Research, the global personal care ingredients market size was estimated at $10.4 billion in 2021 and is expected to hit $18.5 billion by 2031, registering a CAGR of 6.0% from 2022 to 2031. The global personal care ingredients market is analyzed across source, application, ingredient type, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.  

Request Report Sample Copy: https://www.alliedmarketresearch.com/request-sample/4333 

By source, the synthetic segment contributed to around two-thirds of the global personal care ingredients market revenue in 2021, and is expected to dominate by 2031. The natural segment, however, would showcase the fastest CAGR of 6.1% throughout the forecast period. 

Based on application, the skin care segment held more than one-third of the total market revenue in 2021, and is expected to dominate by 2031. The toiletries segment, on the other hand, would manifest the fastest CAGR of 6.7% throughout the forecast period. The other segments analyzed in the report take in industrial haircare, makeup, fragrances, and oral care. 

Based on ingredient type, the UV absorbers segment held more than one-fourth of the total market revenue in 2021, and is expected to dominate by 2031. The rheology control agents segment, on the other hand, would manifest the fastest CAGR of 7.3% throughout the forecast period. The other segments studied in the report include emollients, surfactants, emulsifiers, antimicrobials, hair fixative polymers, and conditioning polymers. 

Enquiry Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/4333 

Based on region, the market across North America generated nearly one-third of the global market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, simultaneously, would manifest the fastest CAGR of 6.5% during the forecast period. The other regions studied in the report include LAMEA and Europe. 

The key market players analyzed in the global personal care ingredients market report include Croda International Plc, Clariant AG, BASF SE, Berkshire Hathaway Inc. (The Lubrizol Corporation), DOW, Inc., J.M. Huber Corporation, Ashland Global Holdings Inc., KCC Corporation (Momentive Performance Materials), Solvay S.A, and Evonik Industries AG. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players. 

Interested in Procuring this Report? Visit Here: https://www.alliedmarketresearch.com/personal-care-ingredients-market/purchase-options  

Key Benefits For Stakeholders 

  • The report provides an in-depth analysis of the global personal care ingredient market trends along with the current and future market forecast. 
  • This report highlights the key drivers, opportunities, and restraints of the market along with the impact analyses during the forecast period. 
  • Porter’s five forces analysis helps analyze the potential of the buyers & suppliers and the competitive scenario of the personal care ingredient industry for strategy building. 
  • A comprehensive global personal care ingredient market analysis covers factors that drive and restrain the market growth. 
  • The qualitative data in this report aims on market dynamics, trends, and developments. 

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. 

Posted on

Dynamic Digital Radiography Market Set to Hit $636.5 Million by 2032: Reports Allied Market Research

keyword

𝘛𝘩𝘦 𝘨𝘭𝘰𝘣𝘢𝘭 𝘥𝘺𝘯𝘢𝘮𝘪𝘤 𝘥𝘪𝘨𝘪𝘵𝘢𝘭 𝘳𝘢𝘥𝘪𝘰𝘨𝘳𝘢𝘱𝘩𝘺 𝘮𝘢𝘳𝘬𝘦𝘵 𝘪𝘴 𝘰𝘯 𝘵𝘩𝘦 𝘳𝘪𝘴𝘦 𝘵𝘩𝘢𝘯𝘬𝘴 𝘵𝘰 𝘧𝘢𝘤𝘵𝘰𝘳𝘴 𝘭𝘪𝘬𝘦 𝘸𝘪𝘥𝘦𝘴𝘱𝘳𝘦𝘢𝘥 𝘢𝘥𝘰𝘱𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘤𝘩𝘳𝘰𝘯𝘪𝘤 𝘥𝘪𝘴𝘦𝘢𝘴𝘦 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘪𝘴, 𝘭𝘰𝘸 𝘳𝘢𝘥𝘪𝘢𝘵𝘪𝘰𝘯 𝘦𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴, 𝘢𝘯𝘥 𝘳𝘦𝘢𝘭-𝘵𝘪𝘮𝘦 𝘪𝘮𝘢𝘨𝘪𝘯𝘨 𝘤𝘢𝘱𝘢𝘣𝘪𝘭𝘪𝘵𝘪𝘦𝘴.

According to Allied Market Research’s report titled “Dynamic Digital Radiography Market,” the market was valued at $225.5 million in 2022 and is projected to reach $636.5 million by 2032, with a compound annual growth rate (CAGR) of 11.0% from 2023 to 2032.

Request Sample of the Report on Dynamic Digital Radiography Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/194915

Dynamic Digital Radiography (DDR) is an innovative low-dose X-ray imaging technology that captures moving anatomical structures in real-time. It can acquire up to 15 consecutive radiographs per second, enabling observation of physiological cycles. Unlike fluoroscopy, DDR produces individual radiographic images, with sizes up to 17″x17″, akin to CT or MRI, derived from digital radiography.

Prime Determinants of Growth:

  • High adoption of dynamic digital radiography equipment in chronic disease diagnosis.
  • Low emission of radiation by dynamic digital radiography equipment.
  • Real-time imaging capabilities of dynamic digital radiography.
  • High cost of dynamic digital radiography equipment acts as a restraint.
  • Rise in awareness about the ALARA (As Low as Reasonably Achievable) principle creates market opportunities.

Orthopedics Segment Dominance:

  • Orthopedics segment held the largest market share in 2022, exceeding half of the market revenue.
  • Expected to maintain leadership status throughout the forecast period.
  • Anticipated to display the fastest CAGR of 11.4% from 2023 to 2032 due to increased traumatic injuries.

Diagnostic Centers Lead:

  • Diagnostic centers segment led the market in 2022, accounting for nearly three-fifths of revenue.
  • Expected to maintain lead position during the forecast period.
  • High adoption of dynamic digital radiography for diagnosing large patient bases drives growth.
  • Hospital segment projected to register the highest CAGR of 11.6% from 2023 to 2032.

North America Dominance:

  • North America segment held the largest market share in 2022, comprising over two-fifths of revenue.
  • Expected to maintain dominance by 2032 due to surge in traumatic injuries and robust healthcare infrastructure.
  • Asia Pacific region to witness highest CAGR of 11.9% during forecast period, driven by prevalence of chronic respiratory diseases and presence of major key players.

Leading Market Players: – 

  • GE Healthcare
  • Koninklijke Philips N.V.
  • Fujifilm Corporation
  • Konica Minolta
  • Shimadzu Corporation
  • Shenzhen Angell technology Co., Ltd.
  • Nanjing Prelove Medical Equipment Co., Ltd.
  • Anode imaging
  • Siemens Healthineers AG
  • Brown Medical Imaging

The report provides a detailed analysis of these key players in the global dynamic digital radiography market. These players have adopted different strategies such as merger and geographical expansion to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

keyword

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/194915

Posted on

Healthcare Claims Management Solutions Market to Hit $20.3 Billion by 2030 | CAGR of 4.7% : Insights and Projections

Allied Market Research has recently introduced a latest research study titled “Global Healthcare Claims Management Solutions Market Outlook and Forecast 2020-2030.” This comprehensive analysis delves into market risks, pinpoints potential opportunities, and furnishes strategic and tactical decision-making support for the duration from 2020 to 2030. The report distinctly focuses on pivotal regions steering market growth while offering invaluable insights into the market’s research and development, drivers of growth, and shifts in investment dynamics within the Global Healthcare Claims Management Solutions Market. Additionally, the study highlights profiles of numerous prominent industry players, such as Oracle Corporation, ALLISCRIPTS HEALTHCARE SOLUTIONS, ATHENAHEALTH INC. COGNIZANT Technology Solution Corporation, Quest Diagnostics, McKesson Corporation, eClinicalWorks LLC, Optum, Inc., The SSI Group, Inc., and GE Healthcare. 

Click To Get Sample Copy: https://www.alliedmarketresearch.com/request-sample/1863  

 

Healthcare Claims Management Solutions Market Statistics: The global healthcare claims management solutions market size was valued at $12.7 billion in 2020, and is projected to reach $20.3 billion by 2030, growing at a CAGR of 4.7% from 2021 to 2030.  

 

The growing importance of Proteomics- 

The growing importance of Healthcare Claims Management Solutions Market lies in its pivotal role in streamlining administrative processes, reducing costs, and improving revenue cycle management within healthcare organizations. As the healthcare landscape evolves, the demand for efficient claims management solutions escalates, driven by factors such as increasing healthcare expenditure, regulatory complexities, and the transition towards value-based care models. Healthcare Claims Management Solutions empower providers to navigate intricate billing and reimbursement procedures, enhance operational efficiency, and ensure timely payments, ultimately optimizing the overall healthcare delivery ecosystem. 

 

Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/1863  

 

The segments and sub-section of Healthcare Claims Management Solutions Market is shown below: 

By Type: Software, Services 

By Deployment Mode: Web-based, Cloud-based, On-premise 

By Region:  

  • North America  (U.S., Canada, Mexico) 
  • Europe  (France, U.K., Italy, Spain, Rest of Europe, Germany) 
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) 
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA) 

 Some of the key players involved in the Market are: Allscripts Healthcare Solutions, Inc., The SSI Groups Inc., COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION, McKesson Corporation, Oracle Corporation, Optum, Inc,, Quest Diagnostics, Athenahealth Inc., eClinicalWorks LLC, GE Healthcare

 

Objectives Of the Report 

  • -To carefully analyze and forecast the size of the Healthcare Claims Management market by value and volume.
  • -To estimate the market shares of major segments of this market.
  • -To showcase the development of the Healthcare Claims Management industry in different parts of the world.
  • -To analyze and study micro-markets in terms of their contributions to the Healthcare Claims Management market, their prospects, and individual growth trends.
  • -To offer precise and useful details about factors affecting the growth of this market.

-To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Healthcare Claims Management market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches. 

 

The Report Addresses the Following Questions about Healthcare Claims Management 

  • What is the business landscape of the Healthcare Claims Management market? 
  • What factors influence business development during the forecast period? 
  • What are the major risks in the Healthcare Claims Management industry? 
  • Which regions offer the best investment opportunities in the market? 
  • What are the opportunities in the Global Healthcare Claims Management Market? 
  • What are the entry strategies into the Healthcare Claims Management Industry? 

 

Introduction about Healthcare Claims Management Solutions Market 

  • Healthcare Claims Management Solutions Market Size (Sales) Market Share by Type (Product Category) 
  • Healthcare Claims Management Solutions Market by Application/End Users 
  • Healthcare Claims Management Solutions(Volume) and Market Share Comparison by Applications 
  • Global Healthcare Claims Management Solutions and Growth Rate (2022-2032) 
  • Healthcare Claims Management Solutions Competition by Players/Suppliers, Region, Type, and Application 
  • Healthcare Claims Management Solutions (Volume, Value, and Sales Price) table defined for each geographic region defined. 
  • Healthcare Claims Management Solutions Players/Suppliers Profiles and Sales Data 
  • Key Raw Materials Analysis & Price Trends 
  • Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis …….and view more in complete table of Contents 

 

Procure Complete Report @ https://www.alliedmarketresearch.com/checkout-final/41f29c6d13baab8fac82a6ac4d94e7f6  

 

Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia. 

 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. 

 

Contact Us: 

David Correa 

Portland, OR, United States 

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,  

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1(855)550-5975 

help@alliedmarketresearch.com  

Web: https://www.alliedmarketresearch.com 

Posted on

Gene Synthesis Market Poised for Remarkable Growth: Allied Market Research Forecasts USD 5.9 Billion Milestone

keyword

According to the report published by, the global gene synthesis market amassed $1.11 billion in 2021, with projections soaring to $5.9 billion by 2031, marking an impressive 18.4% CAGR from 2022 to 2031. This comprehensive report delves into dynamic market shifts, prime segments, strategic investment opportunities, value chains, regional dynamics, and competitive landscapes. A valuable resource for industry stalwarts, newcomers, investors, and stakeholders alike, it serves as a guiding beacon for shaping future strategies and fortifying market presence.

𝘕𝘰𝘳𝘵𝘩 𝘈𝘮𝘦𝘳𝘪𝘤𝘢 𝘪𝘴 𝘱𝘰𝘪𝘴𝘦𝘥 𝘵𝘰 𝘭𝘦𝘢𝘥 𝘪𝘯 𝘳𝘦𝘷𝘦𝘯𝘶𝘦, 𝘸𝘩𝘪𝘭𝘦 𝘵𝘩𝘦 𝘈𝘴𝘪𝘢-𝘗𝘢𝘤𝘪𝘧𝘪𝘤 𝘮𝘢𝘳𝘬𝘦𝘵 𝘪𝘴 𝘧𝘰𝘳𝘦𝘤𝘢𝘴𝘵𝘦𝘥 𝘵𝘰 𝘦𝘹𝘩𝘪𝘣𝘪𝘵 𝘵𝘩𝘦 𝘴𝘸𝘪𝘧𝘵𝘦𝘴𝘵 𝘊𝘈𝘎𝘙 𝘣𝘦𝘵𝘸𝘦𝘦𝘯 2022 𝘢𝘯𝘥 2031.

Download Report Sample- https://www.alliedmarketresearch.com/request-sample/39489

Segmentation Insights:

  • Method-based segmentation illuminates the diverse approaches driving gene synthesis:
  • Solid phase synthesis emerges as the frontrunner, commanding nearly half of the market share in 2021 and poised to sustain dominance in revenue until 2031.
  • PCR-based enzyme synthesis exhibits a promising trajectory, projected to achieve a remarkable CAGR of 18.7% during the forecast period.
  • Chip-based DNA synthesis presents intriguing possibilities, warranting attention amidst technological advancements.
  • End-user segmentation unveils the varied stakeholders driving market demand:
  • Academic and research institutes claim the lion’s share, constituting nearly two-fifths of the market in 2021 and anticipated to maintain leadership in revenue by 2031.
  • Biotech and pharmaceutical companies, diagnostic laboratories, and other segments signify diverse avenues for market engagement and growth.

Regional Dynamics:

  • North America emerges as the epicenter of market activity, commanding a significant share in 2021 and poised for sustained dominance.
  • Asia-Pacific emerges as a burgeoning hub, poised to exhibit the highest CAGR of 19.0% from 2022 to 2031, fueled by rapid technological adoption and research endeavors.
  • Other regions, including Europe and LAMEA, offer distinct opportunities and challenges, warranting nuanced strategies for market penetration.

keyword

Key Player Analysis:

  • The report meticulously scrutinizes key players driving market dynamics, offering a glimpse into their strategies and performance:
  • Expansion initiatives, product launches, strategic partnerships, and innovation underscore the competitive landscape, shaping market dynamics.
  • Insights into business performance, operating segments, and product portfolios equip stakeholders with actionable intelligence to navigate the competitive terrain.

Leading players of the global gene synthesis market analyzed in the research include 𝘉𝘳𝘰𝘰𝘬𝘴 𝘈𝘶𝘵𝘰𝘮𝘢𝘵𝘪𝘰𝘯, 𝘐𝘯𝘤., 𝘉𝘰𝘴𝘵𝘦𝘳 𝘉𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺, 𝘛𝘸𝘪𝘴𝘵 𝘉𝘪𝘰𝘴𝘤𝘪𝘦𝘯𝘤𝘦, 𝘊𝘰𝘥𝘦𝘹 𝘋𝘕𝘈, 𝘉𝘪𝘰𝘮𝘢𝘵𝘪𝘬, 𝘗𝘳𝘰𝘮𝘢𝘣 𝘉𝘪𝘰𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘦𝘴, 𝘐𝘯𝘤., 𝘛𝘩𝘦𝘳𝘮𝘰 𝘍𝘪𝘴𝘩𝘦𝘳 𝘚𝘤𝘪𝘦𝘯𝘵𝘪𝘧𝘪𝘤, 𝘐𝘯𝘤., 𝘎𝘦𝘯𝘴𝘤𝘳𝘪𝘱𝘵 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺, 𝘐𝘯𝘵𝘦𝘨𝘳𝘢𝘵𝘦𝘥 𝘋𝘕𝘈 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘦𝘴, 𝘐𝘯𝘤., 𝘢𝘯𝘥 𝘖𝘳𝘪𝘎𝘦𝘯𝘦 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘦𝘴, 𝘐𝘯𝘤.

Procure Complete Report (280 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/gene-synthesis-market

Posted on

Non-Animal Alternative Testing Market Size to Achieve USD 29.4 Billion by 2030, Fueled by a CAGR of 13.5%: Says Allied Market Research

Non-Animal Alternative Testing Market

Allied Market Research has published a study report with the title Non-Animal Alternative Testing Market Size was Valued at 𝐔𝐒𝐃 𝟗.𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏 and is Projected to Garner 𝐔𝐒𝐃 𝟐𝟗.𝟒 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟎, registering a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟑.𝟓% from 2022 to 2030. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐍𝐨𝐧-𝐀𝐧𝐢𝐦𝐚𝐥 𝐀𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭?

The non-animal alternative testing market is being driven by several factors, including increasing awareness and concern over animal welfare, a growing focus on the development of non-animal testing methods, and the need for more accurate and predictive testing models. Additionally, regulatory bodies and governments are implementing stricter guidelines on animal testing, further driving the demand for non-animal testing methods. The advancements in technology and growing investments in R&D for non-animal testing methods are also contributing to the growth of the market. Furthermore, the increasing demand for safer and more effective products is further boosting the adoption of non-animal testing methods in the cosmetics, pharmaceutical, and chemical industries.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/A25675

𝐓𝐨𝐩 𝐍𝐨𝐧-𝐀𝐧𝐢𝐦𝐚𝐥 𝐀𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:

  • VITROCELL Systems GmbH
  • Evotec SE
  • Biovit
  • MB Research Laboratories
  • Emulate, Inc.
  • TARA Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Hurel Corporation
  • TissUse GmbH

𝐍𝐨𝐧-𝐀𝐧𝐢𝐦𝐚𝐥 𝐀𝐥𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐯𝐞 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐜𝐚𝐧 𝐛𝐞 𝐝𝐨𝐧𝐞 𝐛𝐚𝐬𝐞𝐝 𝐨𝐧 𝐬𝐞𝐯𝐞𝐫𝐚𝐥 𝐟𝐚𝐜𝐭𝐨𝐫𝐬, 𝐢𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠:

By Technology

  • Cell Culture
  • High Throughput
  • Molecular Imaging
  • OMIC Technology

By Method

  • Cellular Assay
  • Biochemical Assay
  • In-silico
  • Ex-vivo

By End User

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Diagnostics
  • Chemicals Industry
  • Food Industry

By region, North America dominated the global market in 2020, whereas the Asia-Pacific region is anticipated to have the fastest growth during the forecast period. Major non-animal alternative testing companies such as Abbott Laboratories are present in the North American region, which is considered to be a major contributor to the expansion. The market for non-animal alternative testing is also anticipated to develop in the coming years due to the ageing population and the incidence of chronic diseases among North American population.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/A25675

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐅𝐨𝐫 𝐒𝐭𝐚𝐤𝐞𝐡𝐨𝐥𝐝𝐞𝐫𝐬

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Non-Animal Alternative Testing Market analysis from 2021 to 2031 to identify the prevailing Non-Animal Alternative Testing Market Opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the Non-Animal Alternative Testing Market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as Non-Animal Alternative Testing Market trends, key players, market segments, application areas, and market growth strategies.

By Region Outlook

  • North America
    (U.S., Canada, Mexico)
  • Europe
    (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific
    (Japan, China, India, Rest of Asia-Pacific)
  • LAMEA
    (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Posted on

Wellness and Activity-based Health Insurance Market: A Comprehensive Study of the Industry Whereabouts

Allied Market Research published a report on the global wellness and activity-based health insurance market that is expected to reach $302.1 billion in 2032. The industry size which was estimated at $97 billion in 2022 is expected to witness an impressive growth of more than three times, at a CAGR of 12.3%. The forecast period is considered between 2023 and 2032. Additionally, the report includes an insightful, detailed study of the market dynamics, contemporary trends, and competitive landscape, providing a detailed overview of the industry. 

Wellness and Activity-based Health Insurance Market
Wellness and Activity-based Health Insurance Market

Request Research Report Sample & TOC: https://www.alliedmarketresearch.com/request-sample/A313936  

Key highlights 

  • The report includes a comprehensive analysis of the market forecast along with the contemporary trends and future estimations to explain the upcoming investment pockets. Information about key drivers, restraints, & opportunities and their impact analysis is provided in the report.  
  • Through an impeccable research methodology consisting of analytical tools like Porter’s five forces and expert interventions, the report also provides high-quality data and refined insights into the industry’s whereabouts.  
  • Furthermore, quantitative analysis helps in determining the market potential during the forecast period, enabling stakeholders to understand how to execute their future growth objectives.  

Factors influencing the market 

The wellness and activity-based health insurance market is influenced by several key factors, including advancements in wearable technology, the rise of preventative healthcare initiatives, and shifting consumer preferences toward personalized wellness solutions. Additionally, regulatory changes, such as incentivizing healthy behaviors and promoting transparency in healthcare pricing, play a significant role in shaping this market. Furthermore, the growing emphasis on value-based care models and the integration of data analytics to assess individual health risks contribute to the evolution of activity-based health insurance offerings. Overall, these factors converge to drive innovation and competitiveness within the activity-based health insurance sector.  

The group plans segment to maintain its leadership status throughout the forecast period 

Based on the type, the individual plans segment held the highest market share in 2022, accounting for nearly three-fifths of the global wellness and activity-based health insurance market revenue, owing to an increase in the adoption of innovative features and riders to enhance policyholder benefits, such as income guarantees, and accelerated death benefits helps to opt for indexed wellness and activity-based health insurance policies in the global market. However, the group plans segment is projected to manifest the highest CAGR of 13.7% from 2023 to 2032, owing to technological advancement and a rise in awareness among the people, which is projected to attract many new consumers. These factors are expected to boost the global market.  

Inquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A313936 

The mental health and well-being program segment to maintain its leadership status throughout the forecast period 

Based on the program, the fitness program segment held the highest market share in 2022, accounting for more than two-thirds of the global wellness and activity-based health insurance market revenue. This is attributed to an expanding consumer base seeking comprehensive life insurance solutions with tailored features. However, the mental health and well-being program segment is projected to manifest the highest CAGR of 13.5% from 2023 to 2032, owing to the increasing convergence of financial services and the rising demand for comprehensive financial solutions.  

The healthcare providers segment to maintain its leadership status throughout the forecast period 

Based on the service provider, the insurance companies segment held the highest market share in 2022, accounting for nearly half of the global wellness and activity-based health insurance market revenue. This is attributed to the increasing demand for health insurance globally, major companies are expanding their product portfolios in different countries to strengthen their presence for these products and solutions in the market. However, the healthcare provider segment is projected to manifest the highest CAGR of 14.8% from 2023 to 2032, owing to the increasing convergence of financial services and the rising demand for comprehensive financial solutions. 

Asia-Pacific to maintain its dominance by 2032 

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than one-third of the global wellness and activity-based health insurance market revenue. The major factors that drive the growth of the market in this region include the presence of key players and the rise in the purchase of insurance. However, the Asia-Pacific region is expected to witness the fastest CAGR of 16.2% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to the surge in adoption of mobile telematics technology by insurance companies among the developing nations such as China and India. 

Segmental orientation 

Type 

  • Individual plans 
  • Group plans 
  • Program 
  • Fitness programs 
  • Mental health and well-being programs 

Service provider 

  • Insurance companies  
  • Healthcare providers 
  • others 

Regional dynamics 

Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2022 and is anticipated to retain its dominance during the forecast period.  

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠: https://www.alliedmarketresearch.com/purchase-enquiry/A313936  

Contemporary trends in the industry, shaping the landscape 

Contemporary trends in the market reflect a shift toward personalized wellness solutions and incentivizing healthy behaviors. This includes the integration of wearable devices and mobile apps to track physical activity, sleep patterns, and nutrition. Insurers are increasingly offering rewards and discounts to policyholders who meet certain health goals or participate in wellness programs. Furthermore, there is a growing emphasis on preventive care and holistic health management, with insurers focusing on proactive measures to improve overall well-being and reduce healthcare costs eventually. These trends highlight the industry’s commitment to promoting healthy lifestyles and empowering individuals to take control of their health. 

Leading companies 

Allied Market Research enlists the names and provides an exhaustive study of the industry leaders, documents their product portfolio, and investigates their overall performance. The key players in the wellness and activity-based health insurance market include: 

  • Cigna Corporation 
  • Humana Inc. 
  • Blue Cross Blue Shield Association 
  • Oscar Health 
  • Welltok, Inc. 
  • Anthem, Inc. 
  • Aetna Inc 
  • Kaiser Permanente 
  • United Health Group 

These players often adopt various strategic moves like mergers, collaborations, partnerships, and acquisitions to stay ahead in the competitive landscape. 

Why choose Allied Market Research?   

  • Exclusive product offerings   
  • Future market opportunities   
  • Latest technological advancements   
  • Quality assurance  
  • Value chain analysis   
  • Post-sales support   
  • Continuous report update   

Allied Market Research’s wellness and activity-based health insurance industry report offers invaluable insights for stakeholders seeking to navigate the evolving landscape, providing comprehensive analysis to inform strategic decisions and drive innovation in the market.  

𝐓𝐨𝐩 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬: 

Mortgage Lending Market 

AI in Insurance Market 

Open Banking Market 

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. 

We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. 

Contact Us:
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com 

Posted on

Fitness App Market Updates: Projected to Cross USD 120.37 by 2030

Fitness App Market

How big is the fitness app market? According to a report published by Allied Market Research, the global fitness app market was estimated to have a value of $13.78 billion in 2020 and is anticipated to reach $120.37 billion by 2030, growing at a CAGR of 24.3% in between the forecast period of 2021 to 2030. The study analyzes drivers, key players and their strategies, size, and important regions for investment.

Market Segmentation:

Device type:

Smartphone: Smartphones serve as the central hub for accessing, tracking, and engaging with fitness apps, providing users with convenient, personalized, and on-the-go solutions for their health and wellness needs.

Tablets: Tablets offer a larger screen size and enhanced visual experience, making them ideal for immersive workouts, detailed data analysis, and interactive engagement with fitness apps.

Wearable devices: Wearable devices seamlessly integrate with fitness apps, providing real-time tracking of biometric data and physical activity levels, thereby enhancing user engagement and facilitating more accurate performance monitoring and goal tracking.

Operating system:

iOS: iOS provides a robust platform for developing fitness apps, offering seamless integration with Apple’s ecosystem, advanced health tracking features through HealthKit, and a large and engaged user base, enhancing the overall user experience and market reach.

Android: Android offers a versatile platform for fitness apps with its wide device compatibility, customizable user interface, and extensive developer tools, enabling diverse and innovative fitness solutions to reach a broad user demographic.

Type:

Exercise & weight loss: Exercise and weight loss features within fitness apps provide users with tailored workout routines, nutritional guidance, and progress-tracking tools, empowering them to achieve their fitness goals effectively and sustainably.

Diet & nutrition: Diet and nutrition components within fitness apps offer personalized meal plans, calorie tracking, and nutritional insights, enabling users to make informed dietary choices and support their overall health and fitness journey.

Activity tracking: Activity tracking features in fitness apps monitor users’ physical movements and exercise routines, providing valuable data insights, personalized feedback, and motivation to help individuals stay active and reach their fitness goals.

Regional Dynamics:

The global fitness app is studied across North America, Asia-Pacific, Europe and LAMEA. North America generated the highest revenue in 2020 and is expected to witness the highest growth rate during the forecast period owing to an increase in demand for modernizing fitness systems across the region.

Request Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/A07465

Key questions answered in the study:

Which region or sub-segment is expected to drive the telehealth market in the forecast period?

What are the key opportunities in the market?

What factors are estimated to drive and restrain the telehealth market growth?

Leading Market Players:

The leaders of the industry include:

  • Addidas
  • Azumio, Inc.
  • FitnessKeeper
  • Nike, Inc.
  • Under Armour, Inc
  • Aaptiv Inc
  • Applico Inc.
  • Fitbit LLC.
  • MyfitnessPal, Inc.
  • Noom Inc.

Factors influencing the growth of the fitness app market

Increasing health consciousness among individuals, driven by concerns about obesity, sedentary lifestyles, and overall wellness, has led to a surge in demand for fitness solutions. Moreover, advancements in technology, particularly in mobile devices and wearables, have made fitness apps more accessible and user-friendly, allowing individuals to easily track their progress and stay motivated.

COVID-19 pandemic accelerated the adoption of fitness apps as people sought alternative ways to stay active while adhering to social distancing measures and gym closures. Additionally, the customization and personalization features offered by many fitness apps cater to diverse user needs and preferences, enhancing their appeal. Furthermore, the rise of virtual coaching and community engagement within these apps fosters a sense of accountability and support, further driving market growth. Combined, these factors create a fertile environment for the continued expansion of the fitness app market.

Enquiry Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A07465

Highlights

The global fitness app market is categorized into operating system, device type, type, and region.

According to type, the exercise & weight loss segment is projected to garner a significant share in the fitness app industry during the forecast period due to increasing instances of obesity.

Region-wise, North America dominated the market in 2020 and is expected to witness the highest growth rate during the forecast period owing to an increase in demand for modernizing fitness systems across the region.

Why Choose Allied Market Research?

  • Exclusive Product Offerings
  • Comprehensive reports
  • Value chain analysis
  • Latest technological advancements
  • Industries’ best analysts
  • Quality assurance
  • Market growth dynamics
  • Post-sales support
  • Future market opportunities
  • Continuous report update

Buy this Premium Research Report: https://www.alliedmarketresearch.com/fitness-app-market/purchase-options

Recent developments in fitness Apps

Recent developments showcase a convergence of cutting-edge technologies and user-centric design. AI algorithms now power personalized workout routines and dietary suggestions, optimizing fitness journeys. Seamless integration with wearables enhances data tracking accuracy, providing users with real-time insights into their progress.

Gamification elements inject fun and motivation, fostering long-term engagement. Augmented reality features bring workouts to life, offering immersive experiences anywhere.

Additionally, social connectivity within apps fosters support networks and accountability, amplifying motivation.

These advancements signify a shift toward holistic and interactive fitness solutions, empowering users to achieve their wellness goals more effectively and sustainably in the digital age.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
help@alliedmarketresearch.com

Posted on

Continued Growth: U.S. Pain Management Drugs Market Set to Surpass $4.82+ Billion by 2031, with a 3.3% CAGR to 2031

𝘚𝘶𝘳𝘨𝘦 𝘪𝘯 𝘱𝘳𝘦𝘷𝘢𝘭𝘦𝘯𝘤𝘦 𝘰𝘧 𝘮𝘶𝘴𝘤𝘭𝘦 𝘴𝘵𝘳𝘢𝘪𝘯 𝘥𝘪𝘴𝘰𝘳𝘥𝘦𝘳𝘴 𝘴𝘶𝘤𝘩 𝘢𝘴 𝘯𝘦𝘤𝘬 𝘱𝘢𝘪𝘯, 𝘴𝘩𝘰𝘶𝘭𝘥𝘦𝘳, 𝘨𝘳𝘰𝘪𝘯 𝘱𝘢𝘪𝘯, 𝘢𝘯𝘥 𝘩𝘢𝘮𝘴𝘵𝘳𝘪𝘯𝘨 𝘪𝘯 𝘵𝘩𝘦 𝘜.𝘚. 𝘥𝘳𝘪𝘷𝘦 𝘵𝘩𝘦 𝘜.𝘚. 𝘱𝘢𝘪𝘯 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘥𝘳𝘶𝘨𝘴 𝘮𝘢𝘳𝘬𝘦𝘵. 𝘉𝘢𝘴𝘦𝘥 𝘰𝘯 𝘵𝘺𝘱𝘦 𝘰𝘧 𝘱𝘢𝘪𝘯, 𝘵𝘩𝘦 𝘤𝘩𝘳𝘰𝘯𝘪𝘤 𝘱𝘢𝘪𝘯 𝘴𝘦𝘨𝘮𝘦𝘯𝘵 𝘢𝘤𝘤𝘰𝘶𝘯𝘵𝘦𝘥 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘩𝘪𝘨𝘩𝘦𝘴𝘵 𝘴𝘩𝘢𝘳𝘦 𝘪𝘯 2021, 𝘩𝘰𝘭𝘥𝘪𝘯𝘨 𝘮𝘰𝘳𝘦 𝘵𝘩𝘢𝘯 𝘵𝘸𝘰-𝘵𝘩𝘪𝘳𝘥 𝘰𝘧 𝘵𝘩𝘦 𝘜.𝘚. 𝘱𝘢𝘪𝘯 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘥𝘳𝘶𝘨𝘴 𝘮𝘢𝘳𝘬𝘦𝘵.

Allied Market Research recently conducted a comprehensive analysis of the U.S. pain management drugs market, revealing significant insights. In 2021, the market boasted a value of $25,174.29 million. Projections indicate substantial growth, with expectations soaring to $34,824.24 million by 2031. This trajectory suggests a steady compound annual growth rate (CAGR) of 3.3% from 2022 through 2031. These figures underscore the persistent demand for effective pain management solutions within the United States, highlighting opportunities for innovation and investment in the pharmaceutical sector.

The U.S. pain management drugs market faced significant challenges during the lockdown period due to disruptions in the supply chain of pain medications. The pandemic-induced restrictions led to a decline in surgeries, resulting in decreased demand for pain management drugs. Additionally, delays in the approval process for various novel pain medications further hampered market growth. These obstacles underscored the vulnerability of the pain management sector to external disruptions and highlighted the need for resilient supply chains and streamlined regulatory processes to ensure uninterrupted access to essential medications during times of crisis.

Get a Sample Copy of this Report@https://www.alliedmarketresearch.com/request-sample/A09451

Historical Overview:

  • The U.S. pain management drugs market was analyzed both qualitatively and quantitatively from 2021 to 2031.
  • It exhibited a Compound Annual Growth Rate (CAGR) of approximately 3.3% during 2022-2031.
  • Most of this growth was attributed to factors such as an effective distribution network for pain management drugs, increased awareness regarding pain disorders, and new drug approvals within the U.S.

Market Dynamics:

  • Growth and innovations in the pharmaceutical industry offer opportunities for the U.S. pain management drugs market.
  • Factors driving market growth include the rise in pain disorders, improved healthcare infrastructure, increased prevalence of chronic diseases among the geriatric population, and a surge in demand for effective pain medicines with fewer side effects.
  • Various factors like elderly individuals experiencing chronic pain, an increase in diabetic neuropathies, sport injuries, and the prevalence of low back pain contribute to market growth.
  • Government spending on pain management treatment, funding from organizations, and counseling efforts further propel market growth.
  • Alternative therapies, side effects of drugs, and misuse hinder market growth, while advancements in drug formulation offer opportunities.
  • The COVID-19 outbreak disrupted the market in 2021 but is expected to witness recovery and stable growth in the coming years.

Segmental Overview:

  • The market is segmented by drug class, indication, and type of pain.
  • Drug classes include NSAIDS, anesthetics, anticonvulsants, anti-migraine agents, antidepressants, opioids, and nonnarcotic analgesics.
  • Indications range from arthritic pain to acute appendicitis, with postoperative pain dominating the market in 2021.
  • Pain types are categorized as chronic and acute, with chronic pain exhibiting the highest revenue and projected highest CAGR.

Competition Analysis:

  • Major players in the U.S. pain management drugs market includePURDUE PHARMA L.P., PFIZER INC., MERCK & CO., INC., NOVARTIS INTERNATIONAL AG, MYLAN N.V., ABBOTT LABORATORIES, JOHNSON & JOHNSON, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, ELI LILY AND COMPANY, GLAXOSMITHKLINE PLC (GSK) , and others.
  • Key strategies include agreements, product approvals, collaborations, and partnerships to enhance product portfolios.

Overall, the U.S. pain management drugs market shows promising growth opportunities driven by various factors such as technological advancements, rising healthcare spending, and strategic collaborations among key players.

Enquire Before Buying@https://www.alliedmarketresearch.com/purchase-enquiry/A09451

Posted on

Protein Assays Market Size to Achieve USD 4,449.02 million by 2032, Fueled by a CAGR of 6.5%: Says Allied Market Research

Protein Assays Market

Allied Market Research published a report, titled, “Protein Assays Market by Product Type (Kits & Reagents and Instruments & Accessories), Technology (Absorbance Based Protein Assay, Colorimetric Based Protein Assay and Fluorometric Based Protein Assay) Application (Drug Discovery and Development and Disease Diagnosis), and End User (Pharmaceutical & Biotechnology Companies, Clinical Laboratories and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032″. According to the report, the global protein assays market was valued at $2,377.93 million in 2022 and is estimated to reach $4,449.02 million by 2032, exhibiting a CAGR of 6.5% from 2023 to 2032.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐓𝐨𝐩 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐀𝐬𝐬𝐚𝐲𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

  • Sartorius AG
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Perkin Elmer Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Abcam PLC
  • Cell Signaling Technology
  • Merck KGaA
  • Bio-Rad Laboratories Inc
  • Bio-Techne

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/A06187

𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐀𝐬𝐬𝐚𝐲𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: –

Based on product type, the kits & reagents segment held the highest market share in 2022, accounting for more than half of the global protein assays market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to increasing need for comprehensive drug discovery and disease diagnostic activities, technological advancements, and the expanding applications of protein assays in healthcare, research, and pharmaceutical industries. However, the instruments & accessories segment is projected to attain significant growth with a CAGR of 6.1% from 2023 to 2032, owing to technological advancements, increased demand for comprehensive diagnostic solutions, cost-efficiency, and the expanding applications in both clinical and research settings.

Based on technology, the absorbance-based protein assays segment held the highest market share in 2022, accounting for more than two-fifths of the global protein assays market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to the advantages offered by absorbance-based protein assay technology such as it has a dynamic range, to detect a wide range of protein concentrations and are often cost-effective compared to other protein quantification methods, such as fluorescence-based assays. However, the colorimetric based protein assays segment is projected to attain a fastest CAGR of 6.2% from 202 to 2032, owing to availability of a large number of key market players that provide colorimetric based protein assay solutions.

Based on application, the drug discovery and development segment held the highest market share in 2022, accounting for more than three-fifths of the global protein assays market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to the growing focus on research fields such as drug discovery, genomics, and proteomics. However, the disease diagnosis segment is projected to attain a fastest CAGR of 6.1% from 202 to 2032, owing to rise in prevalence of cancer, diabetes, and neurodegenerative disorders, and an increase in utilization of protein assays for the early-stage detection of cancer.

Based on end user, the pharmaceutical and biotechnology companies segment held the highest market share in 2022, accounting for more than two-fifths of the global protein assays market revenue and is estimated to maintain its leadership status throughout the forecast period, owing to the fact that several pharmaceutical and biotechnology companies are actively involved in developing and marketing protein assays and the surge in demand for personalized medicine and easy availability of protein assay kits & reagents. However, the others segment is projected to attain a fastest CAGR of 6.3% from 2023 to 2032, owing to increase in the number of R&D activities in the field of protein assays, rapid adoption of protein assays to enhance disease modeling process and to understand biological processes.

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for less than half of the global protein assays market revenue. This is attributed to surge in prevalence of chronic disorders, rapid adoption of advanced diagnostic tools, well-defined regulatory framework and observation guidelines, sophisticated healthcare infrastructure, and strong presence of key players providing protein assays instruments and kits & reagents. However, the Asia-Pacific region is expected to witness the fastest CAGR of 7.4% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to high unmet needs, surge in geriatric population that increases the incidence rate of chronic disease and cancer, improving healthcare spending, lower cost of products and tests, and increase in the investment by the major companies in the developing countries.

𝐖𝐡𝐚𝐭 𝐀𝐫𝐞 𝐭𝐡𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐟𝐨𝐫 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐀𝐬𝐬𝐚𝐲𝐬?

The increase in incidence of chronic disease is escalating demand for advance diagnostic measures and rise in the number of R&D activities in the field of proteomics acts as a key driving factor for the growth of the global protein assays market. However, the high cost associated with protein assays kits and lack of standardized protocols for protein assay are expected to hamper the growth of protein assays market. On the contrary, increase in demand for personalized medicine and technological advancement with ongoing R&D activities are expected to create immense opportunities for the expansion of the global market in the future.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/A06187

Our Market Research Solution Provides You Answer to Below Mentioned Question:

  • Which are the driving factors responsible for the growth of market?
  • Which are the roadblock factors of this market?
  • What are the new opportunities, by which market will grow in coming years?
  • What are the trends of this market?
  • Which are main factors responsible for new product launch?
  • How big is the global & regional market in terms of revenue, sales and production?
  • How far will the market grow in forecast period in terms of revenue, sales and production?
  • Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
  • How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
  • Which region has more opportunities?

By Region Outlook

  • North America
    (U.S., Canada, Mexico)
  • Europe
    (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific
    (Japan, China, India, Rest of Asia-Pacific)
  • LAMEA
    (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Posted on

Incretin-based Drugs Market Size to Achieve USD 73.9 billion by 2032, Fueled by a CAGR of 7.9%: Says Allied Market Research

incretin-based drugs market

Allied Market Research published a report, titled, “Incretin-based Drugs Market by Drug Class (GLP-1 receptor agonists and DPP-4 inhibitors), By Route of Administration (Parenteral and Oral), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2023-2032″. The global incretin-based drugs market was valued at $34.4 billion in 2022 and is projected to reach $73.9 billion by 2032, registering a CAGR of 7.9% from 2023 to 2032.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐃𝐨𝐰𝐧𝐭𝐮𝐫𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: 𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐑𝐞𝐜𝐞𝐬𝐬𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑 𝐨𝐧 𝐭𝐡𝐞 𝐈𝐧𝐜𝐫𝐞𝐭𝐢𝐧-𝐛𝐚𝐬𝐞𝐝 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

  • The pharmaceutical industry is expected to face challenges in terms of R&D funding and market demand. A recession can impact the financial resources available for drug development and slow down the introduction of new incretin-based drugs.
  • Concerns about affordability of these medications may become more prominent during a recession. High drug prices are a persistent issue, and economic hardships may intensify calls for drug pricing reforms.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/657

𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐞 𝐈𝐧𝐜𝐫𝐞𝐭𝐢𝐧-𝐛𝐚𝐬𝐞𝐝 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭?

Key factors driving the growth of the Incretin-based drugs market includes the increasing prevalence of diabetes, particularly type 2 diabetes, across the globe. As more people are diagnosed with type 2 diabetes, there is a surge in demand for innovative therapies such as incretin-based drugs for the treatment. These drugs offer unique benefits in controlling blood sugar levels while reducing the risk of hypoglycemia and other side effects. The market dynamics of incretin medications are also driven by product approvals and launches. Companies introduce new formulations, better delivery systems, and broadening indications for existing drugs to reach a wider range of patients. This wide range of of treatment options gives healthcare providers more options to meet different patient needs, thus increasing the market demand.

𝐓𝐨𝐩 𝐈𝐧𝐜𝐫𝐞𝐭𝐢𝐧-𝐛𝐚𝐬𝐞𝐝 𝐃𝐫𝐮𝐠𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

  • Eli Lilly and Company.
  • Merck & Co., Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Novo Nordisk A/S
  • AstraZeneca plc
  • Takeda Pharmaceutical Company Ltd.
  • Lupin
  • Boehringer Ingelheim International GmbH
  • Novartis AG

𝐈𝐧𝐜𝐫𝐞𝐭𝐢𝐧-𝐛𝐚𝐬𝐞𝐝 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: –

By drug class, the GLP-1 receptor agonist segment held the highest market share in 2022, accounting for nearly three-fourths of the global incretin-based drugs market revenue and is anticipated to be the fastest growing segment during the forecast period. The growth of the segment is mainly attributed to the advancements taking place in GLP-1 receptor agonist segment. Researchers are focusing on the development and launch of new products with increased efficacy and quality, which is further anticipated to boost the market growth during the forecast period.

By route of administration, the parenteral segment accounted for the largest share in 2022, accounting for nearly two-thirds of the global incretin-based drugs market revenue and is anticipated to be the fastest growing segment during the forecast period. The growth is mainly attributed to the significant product launches in injectable forms by the key players in the market. In addition, a surge in approvals for treatment of additional indications for existing incretin-based injectables is also anticipated to boost the market growth during the forecast period.

By distribution channel, the drug stores and retail pharmacies segment dominated the market in terms of revenue in 2022, accounting for more than half of the global market. Their widespread presence and accessibility increase the availability of these treatments to a broad consumer base.

On the other hand, the online providers segment is anticipated to be the fastest growing segment during the forecast period. Online providers offer a convenient platform for purchasing incretin-based drugs. Consumers can access a wide range of medications from various brands through online pharmacies or e-commerce platforms.

North America dominated the market in 2022, accounting for nearly half of the global market, owing to the well-established healthcare infrastructure and availability of highly advanced medical diagnostics and treatment facilities in this region. In addition, high spending on medications is also contributing to the market growth. On the other hand, Asia-Pacific is anticipated to be the fastest growing segment during the forecast period, which is attributed to rising healthcare expenditure, and developing healthcare infrastructure.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/657

Our Market Research Solution Provides You Answer to Below Mentioned Question:

  • Which are the driving factors responsible for the growth of market?
  • Which are the roadblock factors of this market?
  • What are the new opportunities, by which market will grow in coming years?
  • What are the trends of this market?
  • Which are main factors responsible for new product launch?
  • How big is the global & regional market in terms of revenue, sales and production?
  • How far will the market grow in forecast period in terms of revenue, sales and production?
  • Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
  • How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
  • Which region has more opportunities?

By Region Outlook

  • North America
    (U.S., Canada, Mexico)
  • Europe
    (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific
    (Japan, China, India, Rest of Asia-Pacific)
  • LAMEA
    (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.